This review examines the historical use and modern applications of silver nanoparticles (AgNPs) as antibacterial agents, focusing on their mechanisms, physicochemical properties, and potential synergy with antibiotics against resistant pathogens.
Antibiotics · 7 authors, 4 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This review examines the historical use and modern applications of silver nanoparticles (AgNPs) as antibacterial agents, focusing on their mechanisms, physicochemical properties, and potential synergy with antibiotics against resistant pathogens.
This narrative review synthesizes preclinical research on silver nanoparticles (AgNPs) as antibacterial agents. It details the history of silver use, methods for AgNP fabrication, their physicochemical properties, and antibacterial mechanisms against Gram-positive and Gram-negative bacteria, with emphasis on ESKAPE pathogens. The review highlights how AgNP-antibiotic conjugates can synergistically reduce pathogen growth, potentially allowing lower antibiotic doses to mitigate resistance. The authors conclude that despite strong research on efficacy, more work is needed on reproducibility, characterization, and understanding organ effects before mass clinical deployment.